Compounds > n-palmitoylsphingosine

n-palmitoylsphingosine and Cancer of Prostate

n-palmitoylsphingosine has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amoscato, AA; Bennouna, J; Eto, M; Hershberger, PA; Hunter, OC; Johnson, CS; Kanto, T; Lotze, MT1
Amoscato, AA; Bennouna, J; Eto, M; Hunter, OC; Lotze, MT1

Other Studies

2 other study(ies) available for n-palmitoylsphingosine and Cancer of Prostate

ArticleYear
C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells.
    The Prostate, 2003, Sep-15, Volume: 57, Issue:1

    Topics: Adenocarcinoma; Androgens; Apoptosis; Caspase 3; Caspases; Ceramides; G1 Phase; Humans; Male; Mass Spectrometry; Mitochondria; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Resting Phase, Cell Cycle; Tumor Cells, Cultured

2003
Importance of C16 ceramide accumulation during apoptosis in prostate cancer cells.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:2

    Topics: Adenocarcinoma; Androgen Antagonists; Apoptosis; Cell Line, Tumor; Ceramides; Humans; Male; Prostatic Neoplasms

2006